| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | ALLO Allogene Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.68 | 46,003 | 77.29 k | 5,317,237 |
| 24 Jan 25 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 552,174 | 0.00 | 5,363,240 |
| 24 Jan 25 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.94 | 1,952,130 | 3.79 mm | 1,952,130 |
| 16 May 24 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.9 | 344,828 | 1.00 mm | 4,810,106 |
| 14 Mar 24 | ALLO Allogene Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 4.33 | 53,393 | 231.19 k | 4,465,278 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 317,800 | 0.00 | 4,513,203 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.2 | 1,123,535 | 3.60 mm | 1,123,535 |
